If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

4 Dec 2007 16:56

Ark Therapeutics Group PLC04 December 2007 Ark Therapeutics Group plc 4 December 2007 BLOCKLISTING SIX MONTHLY RETURN 1. Name of applicant Ark Therapeutics Group plc 2. Name of scheme Ark Therapeutics Group Enterprise Management Incentive Share Option Plan (the "Scheme") 3. Period of return From 3/6/2007 to 2/12/2007 4. Balance under scheme from previous return 1,045,683 5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return Nil 6. Number of securities issued/allotted under the Scheme during period 24,000 7. Balance under the Scheme not yet issued/allotted at end of period 1,021,683 7. Number and class of securities originally listed and the date of admission 126,220,994 ordinary shares admitted to listing on 8/3/2004 8. Total number of securities in issue at the end of the period 201,938,969 Name of contact: Nick PlummerAddress of contact: 79 New Cavendish Street, London W1W 6XBTelephone number of contact: 0207 388 7722Signed by: Nick PlummerPosition: Company Secretary For and on behalf of Ark Therapeutics Group plc This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Mar 20054:29 pmRNSDirector Shareholding
21st Mar 20054:21 pmRNSDirector Shareholding
14th Mar 20055:55 pmRNSDirector's Share Dealing
14th Mar 20055:06 pmRNSDirector Shareholding
14th Mar 20055:00 pmRNSDirector Shareholding
10th Mar 20057:01 amRNSFinal Results
21st Jan 20057:00 amRNSGranted Patent
19th Jan 20054:21 pmRNSInterest in Shares
17th Jan 20057:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.